OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current status of potential therapeutic candidates for the COVID-19 crisis
Jiancheng Zhang, Bing Xie, Kenji Hashimoto
Brain Behavior and Immunity (2020) Vol. 87, pp. 59-73
Open Access | Times Cited: 287

Showing 1-25 of 287 citing articles:

Attitudes Toward a Potential SARS-CoV-2 Vaccine
Kimberly A. Fisher, Sarah J. Bloomstone, Jeremy Walder, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 12, pp. 964-973
Open Access | Times Cited: 1139

The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria
Douglas B. Kell, Eugene L. Heyden, Etheresia Pretorius
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 365

Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 359-359
Open Access | Times Cited: 356

COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Duraisamy Kempuraj, Govindhasamy Pushpavathi Selvakumar, Mohammad Ejaz Ahmed, et al.
The Neuroscientist (2020) Vol. 26, Iss. 5-6, pp. 402-414
Open Access | Times Cited: 266

A quantitative and qualitative study on the neuropsychiatric sequelae of acutely ill COVID-19 inpatients in isolation facilities
Fengyi Hao, Wilson Tam, Xiaoyu Hu, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 181

Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 175

Biosensors: frontiers in rapid detection of COVID-19
Rachel Samson, Govinda R. Navale, Mahesh Dharne
3 Biotech (2020) Vol. 10, Iss. 9
Open Access | Times Cited: 170

Forecasting of COVID-19 cases using deep learning models: Is it reliable and practically significant?
Jayanthi Devaraj, Rajvikram Madurai Elavarasan, Rishi Pugazhendhi, et al.
Results in Physics (2021) Vol. 21, pp. 103817-103817
Open Access | Times Cited: 153

High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
Yao Zhao, Xiaoyu Du, Yinkai Duan, et al.
Protein & Cell (2021) Vol. 12, Iss. 11, pp. 877-888
Open Access | Times Cited: 134

Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study
Joël Pincemaïl, Étienne Cavalier, Corinne Charlier, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 257-257
Open Access | Times Cited: 120

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
Balasubramanian Ganesh, Thangarasu Rajakumar, Malathi Mathiyazhakan, et al.
Clinical Epidemiology and Global Health (2021) Vol. 10, pp. 100694-100694
Open Access | Times Cited: 117

Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2021) Vol. 271, Iss. 2, pp. 249-258
Open Access | Times Cited: 114

Mechanisms of action of fluvoxamine for COVID-19: a historical review
Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Molecular Psychiatry (2022) Vol. 27, Iss. 4, pp. 1898-1907
Open Access | Times Cited: 107

COVID-19 Sepsis and Microcirculation Dysfunction
A. Colantuoni, Romeo Martini, Patrizia Caprari, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 113

Dysosmia and dysgeusia due to the 2019 Novel Coronavirus; a hypothesis that needs further investigation
Seied Omid Keyhan, Hamid Reza Fallahi, Behzad Cheshmi
Maxillofacial Plastic and Reconstructive Surgery (2020) Vol. 42, Iss. 1
Open Access | Times Cited: 89

Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission
Daniella S. Battagello, Guilherme Dragunas, Marianne Klein, et al.
Clinical Science (2020) Vol. 134, Iss. 16, pp. 2137-2160
Open Access | Times Cited: 86

Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations
Parisorn Thepmankorn, John R. Bach, Ahmed Lasfar, et al.
Cytokine (2020) Vol. 138, pp. 155404-155404
Open Access | Times Cited: 77

Myasthenic crisis in COVID-19
Fadi Delly, Maryam J. Syed, Robert P. Lisak, et al.
Journal of the Neurological Sciences (2020) Vol. 414, pp. 116888-116888
Open Access | Times Cited: 73

Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective
Ashim Gupta, Shivaji Kashte, Manu Gupta, et al.
Human Cell (2020) Vol. 33, Iss. 4, pp. 907-918
Open Access | Times Cited: 73

Zinc against COVID-19? Symptom surveillance and deficiency risk groups
Marcin P. Joachimiak
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 1, pp. e0008895-e0008895
Open Access | Times Cited: 71

Effective Immune Functions of Micronutrients against SARS-CoV-2
Kashaf Junaid, Hasan Ejaz, Abualgasim Elgaili Abdalla, et al.
Nutrients (2020) Vol. 12, Iss. 10, pp. 2992-2992
Open Access | Times Cited: 69

COVID-19 and Hypertension: The What, the Why, and the How
Shah-Abas Muhamad, Azizah Ugusman, Jaya Kumar, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 69

Page 1 - Next Page

Scroll to top